WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000027386) USE OF PROPIONYLCARNITINE FOR THE MANUFACTURE OF A MEDICAMENT FOR INHIBITING SMOOTH MUSCLE CELL PROLIFERATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/027386    International Application No.:    PCT/IT1998/000318
Publication Date: 18.05.2000 International Filing Date: 11.11.1998
IPC:
A61K 31/221 (2006.01), A61K 45/06 (2006.01)
Applicants: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. [IT/IT]; Viale Shakespeare, 47 I-00144 Rome (IT) (For All Designated States Except US).
CALVANI, Menotti [IT/IT]; (IT) (For US Only)
Inventors: CALVANI, Menotti; (IT)
Agent: CAVATTONI-RAIMONDI; Attn: Mrs. A. Raimondi I-00197 Rome (IT)
Priority Data:
Title (EN) USE OF PROPIONYLCARNITINE FOR THE MANUFACTURE OF A MEDICAMENT FOR INHIBITING SMOOTH MUSCLE CELL PROLIFERATION
(FR) PROCEDE D'UTILISATION DE LA L-CARNITINE DE PROPIONYLE POUR FABRIQUER UN MEDICAMENT DESTINE A INHIBER LA PROLIFERATION DES CELLULES MUSCULAIRES LISSES
Abstract: front page image
(EN)The use of propionyl L-carnitine for the preparation of a medicament having inhibiting activity of the proliferation of smooth muscular cells of vascular wall is herein disclosed. Said medicament is useful for the treatment of vascular pathologies, such as atherosclerosis, hypertension, pulmonary hypertensions, restenosis after angioplasty.
(FR)L'invention concerne un procédé d'utilisation de la L-carnitine de propionyle destiné à préparer un médicament présentant une activité d'inhibition de la prolifération des cellules musculaires lisses de la paroi vasculaire. Ce médicament est utilisé pour traiter les pathologies vasculaires, par exemple l'athérosclérose, l'hypertension, l'hypertension artérielle pulmonaire, et la resténose faisant suite à une angioplastie.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: Italian (IT)